RNPEX
Price
$64.37
Change
+$0.52 (+0.81%)
Updated
May 13 closing price
Net Assets
145.83B
TWGGX
Price
$11.48
Change
+$0.11 (+0.97%)
Updated
May 13 closing price
Net Assets
633.15M
Ad is loading...

RNPEX vs TWGGX

Header iconRNPEX vs TWGGX Comparison
Open Charts RNPEX vs TWGGXBanner chart's image
American Funds New Perspective R4
Price$64.37
Change+$0.52 (+0.81%)
VolumeN/A
Net Assets145.83B
American Century Focused Global Gr I
Price$11.48
Change+$0.11 (+0.97%)
VolumeN/A
Net Assets633.15M
RNPEX vs TWGGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNPEX vs. TWGGX commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNPEX is a Buy and TWGGX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 146B vs. TWGGX (633M). RNPEX pays higher dividends than TWGGX: RNPEX (0.55) vs TWGGX (0.09). RNPEX was incepted earlier than TWGGX: RNPEX (23 years) vs TWGGX (26 years). TWGGX (1.08) is less costly to investors than RNPEX (0.76). TWGGX is a more actively managed with annual turnover of: 72.00 vs. RNPEX (24.00). RNPEX has a lower initial minimum investment than TWGGX: RNPEX (250) vs TWGGX (2500). RNPEX annual gain was more profitable for investors over the last year : 8.33 vs. TWGGX (-1.98). RNPEX return over 5 years is better than : 54.50 vs. TWGGX (6.11).
RNPEXTWGGXRNPEX / TWGGX
Total Expense Ratio0.761.0870%
Annual Report Gross Expense Ratio0.761.0870%
Fund Existence23 years26 years-
Gain YTD5.6816.66085%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets146B633M23,065%
Annual Yield % from dividends0.550.09610%
Returns for 1 year8.33-1.98-421%
Returns for 3 years29.662.131,394%
Returns for 5 years54.506.11891%
Returns for 10 years67.03-6.15-1,089%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AHSCX11.21N/A
N/A
Alger Health Sciences C
TRGOX81.26N/A
N/A
T. Rowe Price Lrg Cp Gr Inv
IVIYX37.62N/A
N/A
Macquarie Global Growth Fund Class Y
DRLYX8.40N/A
N/A
BNY Mellon Developed Markets RE Scs - Y
PFPMX38.47N/A
N/A
Parnassus Mid Cap Institutional